Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study

Infection Control and Hospital Epidemiology

Volumn 36, Issue 8, 2015, Pages 936-941

  Bart, Yossi ^a   Paul, Mical ^b   Eluk, Orna ^b   Geffen, Yuval ^a,c   Rabino, Galit ^b   Hussein, Khetam ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Infectious Diseases Unit   (Israel)

^c Clinical Microbiology Laboratory   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE CARRIER; DISEASE CLEARANCE; ENTEROBACTERIACEAE INFECTION; FEMALE; FOLLOW UP; FOREIGN BODY; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; ISRAEL; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RECURRENT INFECTION; RISK FACTOR; AGED; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HETEROZYGOTE; HOSPITAL READMISSION; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PROSTHESES AND ORTHOSES; RECTUM; RECURRENT DISEASE; TIME FACTOR; VERY ELDERLY;

CARBAPENEM DERIVATIVE;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; CARBAPENEMS; CARRIER STATE; CASE-CONTROL STUDIES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; PATIENT READMISSION; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; RECTUM; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 84988844078     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.82     Document Type: Article

References (14)

1. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenemresistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-1435.
2. Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010;50:364-373.
3. Glasner C, Albiger B, Buist G, et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Eurosurveillance 2013;18:9-15.
4. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenemresistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-67.
5. Hussein K, Sprecher H,Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666-671.
6. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007;30:525-529.
7. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007;51:3026-3029.
8. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31:620-626.
9. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-855.
10. Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control 2013;41:190-194.
11. Schechner V, Kotlovsky T, Tarabeia J, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011;32:497-503.
12. Ahn JY, Song JE, Kim MH, et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study. Am J Infect Control 2014;42:621-625.
13. Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrob Chemother 2007;60: 1124-1130.
14. Falagas ME, Kopterides P. Risk factors for the isolation of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006; 64:7-15. risk factors for recurrence of cre carriage 941